The MarketWatch News Department was not involved in the creation of this content. BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sesen today announced the launch of TrialS, a next generation regulatory ...
Fast, gentle, and highly specific glycoprotein labeling compatible with downstream immunofluorescence, enabled by ...
BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sesen today announced the launch of TrialS, a next generation regulatory translation validation platform designed to help life sciences organizations achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback